A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL™, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16- to 26-Year-Old Women. Principal Investigator: Dr. Bartholomew (open for enrollment)
Study Coordinator: Nonna Stepanov 614-293-0075, Kathy Martin 614-293-7030
GOG # 215: A Phase II randomized Study of the effect of Zolendronic acid versus observation on bone mineral density of the lumbar spine in women who elect to undergo surgery that results in removal of both ovaries.
Principal Investigator: David Cohn, Co-PI: Dr. Blumenfeld (open for enrollment)
Study Coordinator: Roberta Cobb 614-293-7582, Nonna Stepanov 614-293-0075
GOG # 214: PHASE II DOUBLE BLIND RANDOMIZED TRIAL OF EVALUATING THE BIOLOGIC EFFECT OF LEVONORGESTREL ON THE OVARIAN EPITHELIUM IN WOMEN AT HIGH RISK FOR OVARIAN CANCER.
Principal Investigator: David Cohn, Co-PI: Dr. Blumenfeld (open for enrollment)
Study Coordinator: Roberta Cobb 614-293-7582, Nonna Stepanov 614-293-0075
A Multi-Center Prospective Clinical Study to Evaluate the Performance and Clinical Predictive Value of the Invader® HPV HR Molecular Assay and Invader® HPV 16 /18 Molecular Assay for the Detection of Human Papillomavirus in Cervical Cytology Samples ( TWT study)
Principal Investigator: Dr. Bartholomew (closed for enrollment)
Study Coordinator: Nonna Stepanov 614-293-0075, Kathy Martin 614-293-7030
Blood loss at the time of first trimester surgical abortion in anticoagulated women Principal Investigator: Dr. Isley, Co-PI: Dr. Keder (open for enrollment)
Study Coordinator: Nonna Stepanov 614-293-0075, Kathy Martin 614-293-7030
TASC: Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing
Principal Investigator: Dr. Keder, Co-PI: Dr. Isley (open for enrollment)
Study Coordinator: Nonna Stepanov 614-293-0075, Kathy Martin 614-293-7030
